Literature DB >> 8252026

Laparoscopic pyelocaliceal diverticula ablation.

G R Gluckman1, M Stoller, P Irby.   

Abstract

Pyelocaliceal diverticula are cystic urine collections within the renal parenchyma communicating with the collecting system. They occur in 0.2% to 0.5% of the population and often contain calculi. Flank pain is the most common complaint, and most lesions are diagnosed by intravenous urography. In the past, treatment has required open renal surgery, with potential loss of renal function, or prolonged percutaneous procedures. We propose surgical treatment of caliceal diverticula by laparoscopic unroofing and fulguration. The benefits include renal preservation as well as decreased morbidity and an earlier return to work for the patient.

Entities:  

Mesh:

Year:  1993        PMID: 8252026     DOI: 10.1089/end.1993.7.315

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  5 in total

Review 1.  Laparoscopic urinary stone surgery: an updated evidence-based review.

Authors:  Andreas Skolarikos; Athanasios G Papatsoris; Stefanos Albanis; Dean Assimos
Journal:  Urol Res       Date:  2010-04-16

2.  Robotic extended pyelolithotomy for treatment of renal calculi: a feasibility study.

Authors:  Ketan K Badani; Ashok K Hemal; Michael Fumo; Sanjeev Kaul; Alok Shrivastava; Arumuga Kumar Rajendram; Noor Ashani Yusoff; Murali Sundram; Susan Woo; James O Peabody; Sahabudin Raja Mohamed; Mani Menon
Journal:  World J Urol       Date:  2006-05-16       Impact factor: 4.226

Review 3.  Calyceal diverticula: a comprehensive review.

Authors:  Nikhil Waingankar; Samih Hayek; Arthur D Smith; Zeph Okeke
Journal:  Rev Urol       Date:  2014

4.  Percutaneous endoscopic treatment for calyceal diverticular calculi.

Authors:  Akiou Okumura; Koich Murakami; Masashi Yoshida; Osamu Nagakawa; Hideki Fuse
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Percutaneous management of caliceal diverticuli.

Authors:  Amy E Krambeck; James E Lingeman
Journal:  J Endourol       Date:  2009-10       Impact factor: 2.942

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.